肥胖指数与慢性肾脏病的研究进展  

Research progress of obesity index and chronic kidney disease

作　　者：王中丽 吴云琪 林瑶 刘红岩 于珮[1,2] Wang Zhongli;Wu Yunqi;Lin Yao;Liu Hongyan;Yu Pei(NHC Key Laboratory of Hormones and Development,Tianjin Key Laboratory of Metabolic Diseases,Tianjin Institute of Endocrinology and Department of Blood Purification Center,Chu Hsien-I Memorial Hospital,Tianjin Medical University,Tianjin 300134,China;Department of Nephrology&Blood Purification Center,The Second Hospital of Tianjin Medical University,Tianjin 300211,China)

机构地区：[1]天津医科大学朱宪彝纪念医院血液净化中心、天津市内分泌研究所、国家卫健委激素与发育重点实验室、天津市代谢性疾病重点实验室,天津300134 [2]天津医科大学第二医院肾内科&肾脏病血液净化中心,天津300211

出　　处：《中国医学前沿杂志(电子版)》2025年第1期6-13,共8页Chinese Journal of the Frontiers of Medical Science(Electronic Version)

基　　金：天津市自然科学基金重点项目(22JCZDJC00590);天津市医学重点学科(专科)建设项目(TJYXZDXK-032A)。

摘　　要：慢性肾脏病(chronic kidney disease,CKD)是一个日益严重的公共健康问题,其患病率在全球范围内逐年增加。肥胖是肾脏疾病发生和发展的重要危险因素,且伴随而来的代谢异常又会进一步加剧疾病进展。因此早期识别和制定预防策略对于改善CKD高危人群的临床结果至关重要。目前肥胖的临床评估指数有很多,但其与CKD发病的相关性研究结果却不尽相同。现对近年来报道的肥胖指数与CKD的相关研究进展进行阐述,为其临床应用与未来研究提供参考。Chronic kidney disease(CKD)is a growing public health problem,with its prevalence increasing year by year worldwide.Obesity is an important risk factor for the development and progression of kidney disease,and the associated metabolic abnormalities further exacerbate disease progression.Therefore,early identification and the formulation of preventative measures are crucial in improving clinical outcomes for individuals predisposed to developing CKD.There are numerous indices available for the clinical evaluation of obesity.However,the findings from studies examining their correlation with incident CKD have been inconsistent.In this paper,the research progress on obesity index and CKD in recent years is reviewed,aiming to offer valuable insights for clinical application and future research.

关 键 词：慢性肾脏病 肥胖指数 相关性 

分 类 号：R692[医药卫生—泌尿科学] R589.2[医药卫生—外科学]